48
Participants
Start Date
August 1, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Enoxaparin
Enoxaparin 4000 IU/day by subcutaneous injection at the time of randomization and continued until delivery. Dose adjustments were made throughout the study based on symptoms such as bleeding and thrombosis.
Aspirin
Aspirin 75mg, orally, once daily at the time of randomization and continued until delivery. Dose adjustments were made throughout the study based on symptoms such as bleeding and thrombosis.
Enoxaparin
Participants in all groups will receive daily injections of enoxaparin at a dose of 4000 IU within 6 weeks at postpartum.
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing
Beijing Obstetrics and Gynecology Hospital
OTHER
Beijing Hospital
OTHER_GOV
Peking Union Medical College Hospital
OTHER
China-Japan Friendship Hospital
OTHER
Sichuan Academy of Medical Sciences
OTHER
Xiangya Hospital of Central South University
OTHER
Chinese PLA General Hospital
OTHER
Beijing Friendship Hospital
OTHER
Beijing Chuiyangliu Hospital
OTHER_GOV
Peking University People's Hospital
OTHER